Introduction {#Sec1}
============

Evidence before this study {#Sec2}
--------------------------

Links between environmental chemicals and human health including self-rated health, hypertension, cardiovascular disease, food allergy, oral health, emotional support, and cognitive function in American adults have emerged in Americans (Shiue [@CR13]; Shiue [@CR14]; Shiue [@CR15]; Shiue [@CR16]; Shiue [@CR17]; Shiue [@CR12]; Shiue [@CR9]; Shiue [@CR10]; Shiue [@CR11]), but the effects from polyaromatic hydrocarbons (PAHs) were less studied, compared to other commonly known environmental chemicals such as heavy metals, arsenic, phenols, phthalates, etc. PAHs constitute a group of chemicals that people could be exposed via vehicle exhausts, asphalt, coal tar, wild fires, agricultural burning, soil, charbroiled foods, and tobacco smoke. Approximately, everyone could be exposed to PAHs on a daily basis from multiple sources. PAH pollution may have significant health implications, and the extent of damage to organisms from PAH exposure could be dependent on several factors including degrees and types of PAH exposure (Ball and Truskewycz [@CR1]).

Knowledge gap {#Sec3}
-------------

Previously, animal models under a laboratory condition using rodents showed that exposure to PAHs adversely affected immunologic health (Luebke et al. [@CR7]). However, research in this topic from human sample has not been well conducted. Providing evidence using human sample might help environmental health promotion in the next few years. Recently, associations of PAHs and cardiovascular, oral, emotional, and self-rated health have been observed (Shiue [@CR13]; Shiue [@CR14]; Shiue [@CR15]; Shiue [@CR16]; Shiue [@CR17]), but those on respiratory health have not been documented.

Study aim {#Sec4}
---------

Following this context, therefore, the aim of the present study was to examine the relationships of urinary PAHs and adult respiratory conditions using a large human sample in a national and population-based setting in recent years.

Methods {#Sec5}
=======

Study sample {#Sec6}
------------

As described elsewhere (Centers for Disease Control and Prevention [@CR2]), United States National Health and Nutrition Examination Surveys (NHANES) has been a national, population-based, multi-year, cross-sectional study. Study samples are representative sample of the civilian, non-institutionalized US population. Information on demographics (more details via <http://wwwn.cdc.gov/nchs/nhanes/2011-2012/DEMO_G.htm>), serum cotinine (more details via <http://wwwn.cdc.gov/nchs/nhanes/2011-2012/COTNAL_G.htm>), and self-reported respiratory health conditions (more details via <http://wwwn.cdc.gov/nchs/nhanes/2011-2012/MCQ_G.htm>) was obtained by household interview using questionnaires. In the current analysis, the 2011--2012 study cohort as the most recent wave with data on urinary PAHs was selected. Informed consents were obtained from participating subjects by the NHANES researchers.

Biomonitoring {#Sec7}
-------------

Urines were only collected in a subsample, being one third of the whole study cohort with representation (more details via <http://www.cdc.gov/nchs/data/nhanes/nhanes_09_10/homeurine.pdf>), to measure environmental chemical concentrations in urines among people aged 6 and above (more details via <http://www.cdc.gov/nchs/nhanes/nhanes2011-2012/labdoc_g.htm>). Urine specimens from urinary polyaromatic hydrocarbon were processed, stored under appropriate frozen (−20 °C) conditions, and shipped to the Division of Environmental Health Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention for analysis. According to the NHANES website (more details via <http://www.cdc.gov/nchs/data/nhanes/nhanes_11_12/PAH_G_met.pdf>), the procedure involved enzymatic hydrolysis of glucuronidated/sulfated OH-polyaromatic hydrocarbon metabolites in urine, extraction, derivatization, and analysis using isotope dilution capillary gas chromatography tandem mass spectrometry (GC-MS/MS). Ion transitions specific to each analyte and carbon-13-labeled internal standards are monitored, and the abundances of each ion are measured. Since urinary hydrocarbon concentrations were highly skewed, they were all log transformed when carrying out the statistical analyses.

Variables and analysis {#Sec8}
----------------------

Adults aged 20 and above were included in the current statistical analysis since chronic diseases were commonly reported in adults. Associations of urinary PAHs and adult self-reported respiratory health conditions were examined by using *t* test and survey-weighted logistic regression model, presenting with mean values, odds ratios (OR), and 95 % confidence intervals (CI). Covariates including urinary creatinine, age, sex, ratio of family income to poverty (proxy of socioeconomic status), body mass index, education level, serum cotinine (biomarker of smoking status), alcohol status, and physical activity level were adjusted. Statistical software STATA version 13.0 (STATA, College Station, Texas, USA) was used to perform all the statistical analyses.

Ethics consideration {#Sec9}
--------------------

Since there is only secondary data analyses employed without any participant personal information identified by extracting statistical data from the NHANES website in the present study, no further ethics approval for conducting the present study is required (more details via <http://www.ethicsguidebook.ac.uk/Secondary-analysis-106>).

Results {#Sec10}
=======

Descriptive statistics {#Sec11}
----------------------

Of 5560 American adults aged 20--80 and included in the statistical analysis, their characteristics are shown in Table [1](#Tab1){ref-type="table"}. The presence of different respiratory health conditions in the American adult population varied and is accordingly presented in Table [2](#Tab2){ref-type="table"}.Table 1Characteristics of the included participants aged 20--80 (*n* = 5560)*N* (%)Age48.9 ± 17.9 20--391957 (35.2 %) 40--591812 (32.6 %) 60--801791 (32.2 %)Sex Male2740 (49.3 %) Female2820 (50.7 %)Body mass index28.8 ± 6.9 \<18.51103 (1.9 %) 18.5--24.91577 (28.4 %) 25--29.91684 (30.3 %) 30+2196 (39.5 %)Ratio of family income to poverty 0--4.94199 (75.5 %) 5+1361 (24.5 %)Education level Less than 9th grade550 (9.9 %) 9--11th grade782 (14.1 %) High school graduate or equivalent1169 (21.0 %) Some college or AA degree1657 (29.8 %) College graduate or above1397 (25.2 %)Serum cotinine (ng/mL)52.1 ± 120.2Alcohol status \>12 drinks3413 (72.8 %) Less than 12 drinks1275 (27.2 %)Physical activity level Engaging moderately2297 (41.3 %) None3262 (58.7 %) Table 2Prevalence of respiratory health conditions in American adults (*n* = 5560)*N* (%)Asthma810 (14.6 %)Emphysema100 (1.8 %)Chronic bronchitis297 (5.4 %)Wheezing749 (13.5 %)Coughing376 (10.4 %)Hay fever879 (15.9 %)Infections1015 (28.4 %)

Analytical statistics {#Sec12}
---------------------

In Tables [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"}, [5](#Tab5){ref-type="table"}, [6](#Tab6){ref-type="table"}, [7](#Tab7){ref-type="table"}, [8](#Tab8){ref-type="table"}, [9](#Tab9){ref-type="table"}, [10](#Tab10){ref-type="table"}, [11](#Tab11){ref-type="table"}, and [12](#Tab12){ref-type="table"}, associations of 10 urinary PAHs and adult respiratory health conditions are listed separately. In general, urinary PAHs were higher in people with emphysema or chronic bronchitis but lower in people with asthma or infections. No associations were found between urinary PAHs and wheezing, coughing, and hay fever. Specifically, urinary 2-hydroxyfluorene and 3-hydroxyfluorene were positively associated with emphysema (OR, 1.60, 95 % CI 1.26 to 2.03, *P* = 0.001 and OR, 1.42, 95 % CI 1.15 to 1.77, *P* = 0.003, respectively) and chronic bronchitis (OR, 1.42, 95 % CI 1.04 to 1.94, *P* = 0.031 and OR, 1.40, 95 % CI 1.03 to 1.91, *P* = 0.036, respectively), while 2-hydroxynaphthalene (2-naphthol) was likely to be borderline associated with emphysema (OR, 1.20, 95 % CI 0.82 to 1.75, *P* = 0.332) and chronic bronchitis (OR, 1.32, 95 % CI 1.02 to 1.72, *P* = 0.038). Conversely, urinary 1-hydroxyphenanthrene, 3-hydroxyphenanthrene, 1-hydroxypyrene, and 4-hydroxyphenanthrene were inversely associated with asthma and infections.Table 3Associations between 2-hydroxyfluorene (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valueAsthma702.3 (1094.0)585.0 (1056.2)0.1120.86 (0.70--1.06)0.144Emphysema1174.7 (1678.9)591.5 (1047.3)0.0051.60 (1.26--2.03)0.001Chronic bronchitis1006.9 (1322.1)578.3 (1042.1)0.00021.42 (1.04--1.94)0.031Wheezing880.6 (1210.7)561.0 (1032.9)\<0.0011.20 (0.89--1.62)0.216Coughing1148.2 (1894.5)523.6 (963.2)\<0.0011.14 (0.77--1.68)0.484Hay fever446.7 (692.0)631.6 (1120.2)0.0070.80 (0.73--1.06)0.165Infections547.8 (918.5)611.7 (1194.3)0.3920.89 (0.76--1.04)0.140^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weighting Table 4Associations between 3-hydroxyfluorene (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valueAsthma341.9 (663.2)288.1 (605.5)0.2090.88 (0.73--1.05)0.152Emphysema600.1 (1004.8)290.6 (605.0)0.0091.42 (1.15--1.77)0.003Chronic bronchitis524.7 (805.6)282.5 (599.5)0.00031.40 (1.03--1.91)0.036Wheezing451.8 (680.3)273.0 (600.6)0.00011.23 (0.93--1.62)0.140Coughing540.9 (794.6)247.2 (563.4)\<0.0011.15 (0.83--1.59)0.369Hay fever216.6 (404.9)310.9 (646.5)0.0180.91 (0.75--1.11)0.319Infections249.3 (466.2)292.4 (649.4)0.2830.89 (0.76--1.04)0.145^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weighting Table 5Associations between 9-hydroxyfluorene (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valueAsthma515.1 (736.7)519.9 (888.3)0.9370.76 (0.64--0.90)0.003Emphysema576.5 (613.8)518.0 (871.9)0.7291.29 (0.87--1.91)0.195Chronic bronchitis678.0 (941.5)509.8 (864.0)0.0791.17 (0.84--1.65)0.328Wheezing615.7 (829.7)504.9 (872.9)0.0801.04 (0.75--1.43)0.812Coughing764.4 (999.1)486.6 (700.8)0.00011.15 (0.74--1.77)0.511Hay fever439.0 (615.0)533.3 (910.6)0.0950.95 (0.81--1.10)0.447Infections476.5 (629.8)535.8 (788.5)0.2320.85 (0.70--1.04)0.109^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weighting Table 6Associations between 1-hydroxyphenanthrene (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valueAsthma196.5 (216.6)202.8 (295.5)0.7490.68 (0.55--0.83)0.001Emphysema206.6 (239.7)201.7 (286.4)0.9301.03 (0.57--1.87)0.918Chronic bronchitis218.4 (206.5)200.7 (289.4)0.5750.97 (0.61--1.55)0.883Wheezing203.4 (202.3)201.6 (295.7)0.9300.87 (0.70--1.09)0.214Coughing269.6 (708.8)193.2 (230.0)0.0150.99 (0.66--1.47)0.953Hay fever178.8 (211.3)206.0 (298.3)0.1420.91 (0.78--1.06)0.205Infections176.8 (176.5)213.0 (362.0)0.0880.78 (0.64--0.96)0.019^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weighting Table 7Associations between 2-hydroxyphenanthrene (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valueAsthma111.3 (123.0)108.3 (156.5)0.7800.83 (0.67--1.02)0.067Emphysema117.5 (111.8)108.5 (152.8)0.7601.42 (0.96--2.09)0.077Chronic bronchitis123.7 (105.8)107.9 (154.3)0.3511.24 (0.76--2.02)0.359Wheezing113.2 (105.8)108.0 (157.7)0.6401.04 (0.79--1.38)0.766Coughing143.1 (313.8)101.3 (121.1)0.0061.01 (0.66--1.55)0.961Hay fever94.7 (113.8)111.4 (158.8)0.0930.95 (0.78--1.17)0.630Infections90.2 (88.2)112.8 (174.2)0.0290.81 (0.64--1.04)0.091^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weighting Table 8Associations between 3-hydroxyphenanthrene (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valueAsthma122.8 (160.7)122.6 (237.8)0.9910.77 (0.63--0.93)0.008Emphysema121.1 (150.5)122.6 (229.6)0.9730.97 (0.60--1.58)0.902Chronic bronchitis144.2 (179.4)121.2 (230.8)0.3641.12 (0.77--1.64)0.529Wheezing129.6 (150.0)121.6 (237.6)0.6291.06 (0.80--1.39)0.670Coughing191.3 (624.9)109.1 (149.2)0.0011.06 (0.73--1.55)0.742Hay fever100.5 (136.0)126.9 (242.9)0.0750.89 (0.76--1.04)0.124Infections93.0 (101.3)129.1 (289.7)0.0300.76 (0.63--0.92)0.008^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weighting Table 9Associations between 1-hydroxypyrene (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valueAsthma217.2 (306.8)200.7 (333.0)0.4700.79 (0.65--0.96)0.019Emphysema229.5 (377.8)202.5 (328.7)0.6731.07 (0.70--1.62)0.740Chronic bronchitis248.7 (310.1)200.2 (330.4)0.1811.30 (0.91--1.87)0.140Wheezing239.2 (328.5)197.7 (329.2)0.0841.05 (0.80--1.37)0.727Coughing280.5 (609.3)175.0 (288.1)0.0020.99 (0.70--1.42)0.968Hay fever176.8 (282.0)207.8 (336.9)0.1470.84 (0.71--1.00)0.046Infections168.4 (274.4)194.9 (363.3)0.2410.83 (0.72--0.97)0.020^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weighting Table 10Associations between 1-hydroxynaphthalene (1-naphthol) (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valueAsthma65,790.7 (827,032.2)32,590.7 (555,198.9)0.4270.93 (0.79--1.10)0.377Emphysema13,920.9 (28,619.5)37,656.7 (605,732.7)0.8391.07 (0.83--1.38)0.576Chronic bronchitis170,804.4 (1,371,824.0)30,136.6 (529,120.2)0.0341.06 (0.85--1.32)0.572Wheezing76,277.2 (874,264.1)31,635.6 (550,415.4)0.3091.01 (0.82--1.24)0.945Coughing142,167.3 (1,196,975.0)45,590.4 (682,159.8)0.1941.18 (0.94--1.49)0.143Hay fever107,878.5 (1,239,498.0)23,182.9 (354,243.4)0.0300.91 (0.74--1.12)0.348Infections142,826.6 (1,345,310.0)19,376.2 (205,077.5)0.0140.97 (0.79--1.19)0.751^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weighting Table 11Associations between 2-hydroxynaphthalene (2-naphthol) (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valueAsthma9851.4 (11,745.6)8756.0 (12,149.8)0.1930.88 (0.74--1.04)0.134Emphysema11,964.7 (15,808.4)8852.3 (12,026.0)0.1851.20 (0.82--1.75)0.332Chronic bronchitis11,858.9 (13,145.8)8732.6 (12,024.7)0.0191.32 (1.02--1.72)0.038Wheezing12,355.6 (17,029.1)8409.5 (11,124.2)\<0.0011.09 (0.86--1.38)0.462Coughing12,665.5 (21,306.8)7687.7 (10,106.7)\<0.0011.13 (0.78--1.65)0.490Hay fever6621.9 (7993.0)9359.7 (12,725.6)0.0010.86 (0.71--1.03)0.097Infections8501.7 (11,200.4)8136.1 (12,233.8)0.6460.96 (0.76--1.22)0.714^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weighting Table 12Associations between 4-hydroxyphenanthrene (ng/L) and adult health (*n* = 1670)PresentAbsent*P* valueOR (95 % CI)^a^*P* valueAsthma42.4 (79.9)33.9 (44.9)0.0170.80 (0.67--0.94)0.012Emphysema35.5 (39.1)35.1 (51.6)0.9641.05 (0.58--1.88)0.872Chronic bronchitis41.5 (39.3)34.7 (52.0)0.2331.18 (0.83--1.68)0.327Wheezing37.7 (35.9)34.7 (53.2)0.4191.06 (0.79--1.41)0.681Coughing38.0 (41.8)33.8 (55.2)0.4301.08 (0.66--1.78)0.733Hay fever31.8 (51.0)35.7 (51.5)0.2400.96 (0.81--1.14)0.625Infections29.5 (32.4)36.4 (60.9)0.0580.74 (0.58--0.94)0.016^a^Adjusted for urine creatinine, age, sex, body mass index, ratio of family income to poverty, education level, serum cotinine, alcohol habit, physical activity level, and subsampling weighting

Discussion {#Sec13}
==========

PAHs, emphysema, and chronic bronchitis {#Sec14}
---------------------------------------

In animal studies, bitumen fumes or traffic exposure releasing hydrocarbons were observed to result in emphysema in rats (Gate et al. [@CR3]; Wang et al. [@CR18]). However, evidence from human sample was lacking. Consistent with the findings in the animal studies mentioned above, the present study has provided epidemiological evidence on the relationship of PAHs and emphysema from a large human sample. Moreover, the link between PAHs and adult chronic bronchitis has been continuously documented. Previous evidence was obtained in 598 Brazilian male workers (Mendonça et al. [@CR8]), 211 Swedish loggers (Hagberg et al. [@CR4]), and 138 Polish steel mill workers (Kolarzyk et al. [@CR6]). Again, consistent with these studies, the present study has further provided epidemiological evidence drawn from the general population to report such association.

PAHs, asthma, and infections {#Sec15}
----------------------------

The link of PAHs and asthma has not been established and that of PAHs and infections has not been well documented as well. Similar to a previous study in 184 American volunteers showing urinary 1-hydroxypyrene was observed to be less in people with hepatitis virus infection (Johnson et al. [@CR5]), the present study also presented the inverse associations of 1-hydroxyphenanthrene, 3-hydroxyphenanthrene, 1-hydroxypyrene, and 4-hydroxyphenanthrene and infections in the general population. However, the mechanism is unknown and would need longitudinal and/or experimental research to confirm or refute the finding.

Strengths and limitations {#Sec16}
-------------------------

The present study has a few strengths. Firstly, this study was conducted in a large and nationally representative human sample with mixed ethnicities and socioeconomic status. Secondly, this is the first time to examine the effects of urinary hydrocarbon concentrations on adult respiratory health conditions by symptoms. However, there are also a few limitations that cannot be ignored. First, there could be still other emerging chemicals from the living environments through different channels/vehicles that we might not yet know and would need future research to further identify and examine. Second, causality cannot be established in the present study due to the cross-sectional study design in nature. Taken together, future studies retaining the strengths and overcoming the limitations with a longitudinal and/or experimental study design to confirm or refute the current findings and, if at all, to understand the persisting effects along the life course from early years to old age would be recommended.

Directions for future research, practice, and policy {#Sec17}
----------------------------------------------------

In conclusion, urinary PAHs were positively associated with emphysema and chronic but inversely associated with asthma and infections. There were no associations between urinary PAHs and wheezing, coughing, and hay fever found. For future research, studies using large human sample across regions to longitudinally monitor would be suggested. For practice and policy-making, regulation on minimizing polyaromatic hydrocarbons exposure to protect respiratory health might need to be considered in future health and environmental policies and intervention programs.
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